Janoshik Lab
Lab Result: Retatrutide 20mg
(Batch RET17)
Avg. purity
99.75%
Avg. mass:
20.93 mg
Result Date
January 15, 2026
Date added
March 24, 2026
Each vial contains 20mg of highly pure Retatrutide.
Retatrutide is classified as a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors), making it more effective for body fat mass reduction than its predecessor Semaglutide by targeting further receptors.
Add 2mL of bacteriostatic water to get a solution that is 10mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 1mg of Retatrutide.
This product must be refrigerated after reconstitution.

